Venus Remedies - Quaterly Results

29 Oct 2024 Evaluate
Revenue showed a marginal decline at Rs. 1670.20 millions. For the quarter ended September 2024, as compared to corresponding quarter of last year.Profit for the quarter ended September 2024 rises by 69.91% to Rs. 92.60  millions from Rs. 54.50 millions.Operating profit surged to 209.80 millions from the corresponding previous quarter of 160.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1670.20 1701.90 -1.86 2728.80 2688.20 1.51 5752.10 5376.60 6.98
Other Income 107.10 29.30 265.53 122.70 49.90 145.89 113.20 101.70 11.31
PBIDT 209.80 160.60 30.64 368.20 315.90 16.56 722.00 717.00 0.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 209.80 160.60 30.64 368.20 315.90 16.56 722.00 717.00 0.70
Depreciation 61.70 62.10 -0.64 119.30 135.30 -11.83 255.50 313.70 -18.55
PBT 148.10 98.50 50.36 248.90 180.60 37.82 466.50 403.30 15.67
TAX 55.50 44.00 26.14 111.80 82.70 35.19 161.50 113.70 42.04
Deferred Tax 18.30 7.20 154.17 49.20 12.00 310.00 39.30 113.70 -65.44
PAT 92.60 54.50 69.91 137.10 97.90 40.04 305.00 289.60 5.32
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 12.56 9.44 33.12 13.49 11.75 14.82 12.55 13.34 -5.88

Venus Remedies Share Price

785.35 -7.25 (-0.91%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×